Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bramah N Singh

Showing results (1-10 of 39) with videos related to

Pageof 4
Sort By:
Journal of Cardiovascular Pharmacology and Therapeutics|June 21, 2002
Antiarrhythmic drugs in cardiac arrest resuscitation: intravenous amiodarone or intravenous lidocaine?Bramah N Singh
Journal of Cardiovascular Pharmacology and Therapeutics|June 17, 2003
Classes of antianginal compounds: old and new--therapeutic implicationsBramah N Singh
Journal of Cardiovascular Pharmacology and Therapeutics|January 29, 2005
Pursuit of sinus rhythm in patients with atrial fibrillation: is the effort worth it?Bramah N Singh
Current Cardiology Reports|September 8, 2006
Amiodarone: a multifaceted antiarrhythmic drugBramah N Singh
Journal of Cardiovascular Pharmacology|October 9, 2008
Amiodarone as paradigm for developing new drugs for atrial fibrillationBramah N Singh
Journal of Cardiovascular Pharmacology and Therapeutics|September 17, 2002
Atrial fibrillation following investigation of rhythm management: AFFIRM trial outcomes. What might be their implications for arrhythmia control?Bramah N Singh
Current Cardiology Reports|August 10, 2002
Amiodarone as compared to lidocaine for shock-resistant ventricular fibrillationBramah N Singh
Journal of Cardiovascular Pharmacology and Therapeutics|March 26, 2003
Ventricular rate control in atrial fibrillation: what is the optimal rate? The concept of controlling the heart rate burdenBramah N Singh
Journal of Cardiovascular Pharmacology and Therapeutics|May 15, 2003
Atrial fibrillation: epidemiologic considerations and rationale for conversion and maintenance of sinus rhythmBramah N Singh
Journal of Cardiovascular Pharmacology and Therapeutics|June 21, 2005
Atrial fibrillation: the rate or rhythm controversy can it be resolved on the basis of clinical trial data?Bramah N Singh
Pageof 4

Showing results (1-10 of 39) with videos related to

Sort By:
Pageof 4
Journal of Cardiovascular Pharmacology and Therapeutics|June 21, 2002
Antiarrhythmic drugs in cardiac arrest resuscitation: intravenous amiodarone or intravenous lidocaine?Bramah N Singh
Journal of Cardiovascular Pharmacology and Therapeutics|June 17, 2003
Classes of antianginal compounds: old and new--therapeutic implicationsBramah N Singh
Journal of Cardiovascular Pharmacology and Therapeutics|January 29, 2005
Pursuit of sinus rhythm in patients with atrial fibrillation: is the effort worth it?Bramah N Singh
Current Cardiology Reports|September 8, 2006
Amiodarone: a multifaceted antiarrhythmic drugBramah N Singh
Journal of Cardiovascular Pharmacology|October 9, 2008
Amiodarone as paradigm for developing new drugs for atrial fibrillationBramah N Singh
Journal of Cardiovascular Pharmacology and Therapeutics|September 17, 2002
Atrial fibrillation following investigation of rhythm management: AFFIRM trial outcomes. What might be their implications for arrhythmia control?Bramah N Singh
Current Cardiology Reports|August 10, 2002
Amiodarone as compared to lidocaine for shock-resistant ventricular fibrillationBramah N Singh
Journal of Cardiovascular Pharmacology and Therapeutics|March 26, 2003
Ventricular rate control in atrial fibrillation: what is the optimal rate? The concept of controlling the heart rate burdenBramah N Singh
Journal of Cardiovascular Pharmacology and Therapeutics|May 15, 2003
Atrial fibrillation: epidemiologic considerations and rationale for conversion and maintenance of sinus rhythmBramah N Singh
Journal of Cardiovascular Pharmacology and Therapeutics|June 21, 2005
Atrial fibrillation: the rate or rhythm controversy can it be resolved on the basis of clinical trial data?Bramah N Singh
Pageof 4